×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
GMED – globus medical, inc. class a (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
GMED
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/6
07:32 am
gmed
Globus Medical Expands Musculoskeletal Reach With New Technologies And M&A Integration [Yahoo! Finance]
Low
Report
Globus Medical Expands Musculoskeletal Reach With New Technologies And M&A Integration [Yahoo! Finance]
3/5
10:43 am
gmed
Globus Medical (GMED) Slips on Acquisition and Robotics Segment Challenges [Yahoo! Finance]
Low
Report
Globus Medical (GMED) Slips on Acquisition and Robotics Segment Challenges [Yahoo! Finance]
3/5
10:22 am
gmed
Is This the Right Time to Add Globus Medical Stock to Your Portfolio? [Yahoo! Finance]
Low
Report
Is This the Right Time to Add Globus Medical Stock to Your Portfolio? [Yahoo! Finance]
3/5
07:56 am
gmed
Globus Medical (GMED) was upgraded by Zacks Research from "hold" to "strong-buy".
Low
Report
Globus Medical (GMED) was upgraded by Zacks Research from "hold" to "strong-buy".
2/26
10:59 am
gmed
Globus Medical (GMED) had its price target raised by Wells Fargo & Company from $98.00 to $104.00. They now have an "overweight" rating on the stock.
Low
Report
Globus Medical (GMED) had its price target raised by Wells Fargo & Company from $98.00 to $104.00. They now have an "overweight" rating on the stock.
2/26
09:13 am
gmed
Carillon Chartwell Mid Cap Value Fund Q4 2025 Commentary [Seeking Alpha]
Low
Report
Carillon Chartwell Mid Cap Value Fund Q4 2025 Commentary [Seeking Alpha]
2/25
01:11 pm
gmed
Globus Medical (GMED) was given a new $115.00 price target by Truist Financial Corporation.
Low
Report
Globus Medical (GMED) was given a new $115.00 price target by Truist Financial Corporation.
2/25
10:58 am
gmed
Globus Medical (GMED) had its price target raised by Barclays PLC from $118.00 to $123.00. They now have an "overweight" rating on the stock.
Low
Report
Globus Medical (GMED) had its price target raised by Barclays PLC from $118.00 to $123.00. They now have an "overweight" rating on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
2/24/2026
04:15 pm
GMED
globus medical, inc. class a
BEAT
Report
3.8%
globus medical, inc. class a
11/6/2025
04:15 pm
GMED
globus medical, inc. class a
BEAT
Report
35.9%
globus medical, inc. class a
8/7/2025
04:15 pm
GMED
globus medical, inc. class a
BEAT
Report
8.5%
globus medical, inc. class a
5/8/2025
04:15 pm
GMED
globus medical, inc. class a
MISS
Report
-23.0%
globus medical, inc. class a
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
2/27
05:54 pm
gmed
Form 4 GLOBUS MEDICAL INC For: Feb 25 Filed by: Huller Kelly
Low
Report
Form 4 GLOBUS MEDICAL INC For: Feb 25 Filed by: Huller Kelly
2/25
03:41 pm
gmed
Form 144 GLOBUS MEDICAL INC Filed by: Huller Kelly
Low
Report
Form 144 GLOBUS MEDICAL INC Filed by: Huller Kelly
2/24
05:09 pm
gmed
Form 10-K GLOBUS MEDICAL INC For: Dec 31
Medium
Report
Form 10-K GLOBUS MEDICAL INC For: Dec 31
2/24
04:24 pm
gmed
Form 8-K GLOBUS MEDICAL INC For: Feb 24
Medium
Report
Form 8-K GLOBUS MEDICAL INC For: Feb 24
2/17
05:23 pm
gmed
Form 4 GLOBUS MEDICAL INC For: Feb 12 Filed by: Huller Kelly
Low
Report
Form 4 GLOBUS MEDICAL INC For: Feb 12 Filed by: Huller Kelly
2/12
12:13 pm
gmed
Form 144 GLOBUS MEDICAL INC Filed by: Huller Kelly
Low
Report
Form 144 GLOBUS MEDICAL INC Filed by: Huller Kelly
1/23
05:12 pm
gmed
Form 4 GLOBUS MEDICAL INC For: Jan 21 Filed by: Norwalk Leslie V
Low
Report
Form 4 GLOBUS MEDICAL INC For: Jan 21 Filed by: Norwalk Leslie V
1/23
05:10 pm
gmed
Form 4 GLOBUS MEDICAL INC For: Jan 21 Filed by: Pfeil Keith W
Low
Report
Form 4 GLOBUS MEDICAL INC For: Jan 21 Filed by: Pfeil Keith W
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
8/1
Globus Medical Reports Second Quarter 2019 Results
8.5%
4/16 Globus Medical Schedules First Quarter 2020 Earnings Release and Conference Call 6.4%
11/6 Q3/2019 9/30/2019 EPS 0.430 ZacksConsensus 0.430 ActVsEst 0.000 - In-Line 3.2%
3/27 Globus Medical Inc (NYSE: GMED) had its price target lowered by analysts at Morgan Stanley from $60.00 to $48.00. They now have an "equal weight" rating on the stock. 2.8%
11/8 Globus Medical Inc (NYSE: GMED) had its price target raised by analysts at Piper Jaffray Companies from $62.00 to $65.00. They now have an "overweight" rating on the stock. 1.8%
12/11 Globus Medical: 3 Keys To Investing In Late-Cycle Markets [Seeking Alpha] 1.6%
5/3 Form 3 GLOBUS MEDICAL INC For: May 01 Filed by: ZARRILLI STEPHEN T 1.5%
2/4 Medical Devices Are Key to Solving the Healthcare Industry's Persistent Problems 1.2%
12/17 Form 3 GLOBUS MEDICAL INC For: Dec 11 Filed by: Douglas Robert Andrew 1.1%
3/11 Globus Medical Announces $200 Million Share Repurchase Program 1.1%
4/16 Globus Medical Schedules First Quarter 2020 Earnings Release and Conference Call 6.4%
11/6 Q3/2019 9/30/2019 EPS 0.430 ZacksConsensus 0.430 ActVsEst 0.000 - In-Line 3.2%
3/27 Globus Medical Inc (NYSE: GMED) had its price target lowered by analysts at Morgan Stanley from $60.00 to $48.00. They now have an "equal weight" rating on the stock. 2.8%
11/8 Globus Medical Inc (NYSE: GMED) had its price target raised by analysts at Piper Jaffray Companies from $62.00 to $65.00. They now have an "overweight" rating on the stock. 1.8%
12/11 Globus Medical: 3 Keys To Investing In Late-Cycle Markets [Seeking Alpha] 1.6%
5/3 Form 3 GLOBUS MEDICAL INC For: May 01 Filed by: ZARRILLI STEPHEN T 1.5%
2/4 Medical Devices Are Key to Solving the Healthcare Industry's Persistent Problems 1.2%
12/17 Form 3 GLOBUS MEDICAL INC For: Dec 11 Filed by: Douglas Robert Andrew 1.1%
3/11 Globus Medical Announces $200 Million Share Repurchase Program 1.1%
TOP News Decliners
1/8
Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results
-6.8%
3/18 Globus Medical Inc (NYSE: GMED) was upgraded by analysts at BTIG Research from a "neutral" rating to a "buy" rating. -4.0%
1/10 Globus Medical Inc (NYSE: GMED) had its "buy" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $64.00 price target on the stock. -2.8%
2/24 Globus Medical Inc (NYSE: GMED) had its "buy" rating re-affirmed by analysts at Credit Suisse Group AG. They now have a $67.00 price target on the stock. -2.1%
2/20 Q4/2019 12/31/2019 EPS 0.490 ZacksConsensus 0.510 ActVsEst (0.020) - Miss -1.9%
1/2 Is Globus Medical, Inc.'s (NYSE:GMED) 11% ROE Strong Compared To Its Industry? [Yahoo! Finance News] -1.9%
8/3 Globus Medical, Inc. (GMED) CEO Dave Demski on Q2 2019 Results - Earnings Call Transcript [Seeking Alpha] -1.8%
9/24 Globus Medical Launches AUTOBAHN® Intramedullary Nailing Platform at 2019 OTA Annual Meeting -1.7%
2/6 Globus Medical Schedules Fourth Quarter and Full Year 2019 Earnings Release and Conference Call -1.6%
10/8 Globus Medical Inc (NYSE: GMED) had its price target raised by analysts at Wells Fargo & Co from $42.00 to $53.00. They now have a "market perform" rating on the stock. -1.4%
3/18 Globus Medical Inc (NYSE: GMED) was upgraded by analysts at BTIG Research from a "neutral" rating to a "buy" rating. -4.0%
1/10 Globus Medical Inc (NYSE: GMED) had its "buy" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $64.00 price target on the stock. -2.8%
2/24 Globus Medical Inc (NYSE: GMED) had its "buy" rating re-affirmed by analysts at Credit Suisse Group AG. They now have a $67.00 price target on the stock. -2.1%
2/20 Q4/2019 12/31/2019 EPS 0.490 ZacksConsensus 0.510 ActVsEst (0.020) - Miss -1.9%
1/2 Is Globus Medical, Inc.'s (NYSE:GMED) 11% ROE Strong Compared To Its Industry? [Yahoo! Finance News] -1.9%
8/3 Globus Medical, Inc. (GMED) CEO Dave Demski on Q2 2019 Results - Earnings Call Transcript [Seeking Alpha] -1.8%
9/24 Globus Medical Launches AUTOBAHN® Intramedullary Nailing Platform at 2019 OTA Annual Meeting -1.7%
2/6 Globus Medical Schedules Fourth Quarter and Full Year 2019 Earnings Release and Conference Call -1.6%
10/8 Globus Medical Inc (NYSE: GMED) had its price target raised by analysts at Wells Fargo & Co from $42.00 to $53.00. They now have a "market perform" rating on the stock. -1.4%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: